Ohio State Navbar

Sign In

RSS Feed Regenerative Medicine News

Cellectis Gets NIH Contract Worth $9.5M 



Cellectis Gets NIH Contract Worth $9.5M 

October 16, 2012 - (Mass High Tech) - "Cellectis bioresearch Inc., the Cambridge-based subsidiary of Cellectis Group in Paris, has received a five-year contract worth up to $9.5 million from the National Institutes of Health (NIH) to develop stem cell technologies. Under the contract, Cellectis will generate clinical-grade, induced pluripotent stem (iPS) cells, which are stem cells created artificially from adult human cells."  Read Full Article


Posted on 18-Oct-12 by Gallerno, Jacob
Tags: Science and Industry News
Trackback Url  |  Link to this post | Bookmark this post with: